A detailed history of Fulcrum Asset Management LLP transactions in Johnson & Johnson stock. As of the latest transaction made, Fulcrum Asset Management LLP holds 8,726 shares of JNJ stock, worth $1.74 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
8,726
Previous 8,580 1.7%
Holding current value
$1.74 Million
Previous $1.31 Billion 23.45%
% of portfolio
1.19%
Previous 1.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 18, 2025

BUY
$155.17 - $185.42 $22,654 - $27,071
146 Added 1.7%
8,726 $1.62 Billion
Q2 2025

Aug 12, 2025

BUY
$146.36 - $159.82 $1.26 Million - $1.37 Million
8,580 New
8,580 $1.31 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Fulcrum Asset Management LLP Portfolio

Follow Fulcrum Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Asset Management LLP with notifications on news.